Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

FDA
FDA Launches Elsa 4.0 AI Tool, Completes Data Platform Consolidation

The FDA announced the launch of Elsa 4.0, an upgraded internal AI tool now available to all agency staff including scientific reviewers and investigat...

FDA
FDA Pilots One-Day Inspectional Assessments to Boost Oversight Efficiency

The FDA announced a pilot program for one-day inspectional assessments to make its inspectional resources more targeted and efficient. The initiative ...

SANDOZ
FDA Approves Unknown Drug — SANDOZ

# FDA Approves Sandoz Generic Drug Application Sandoz has received FDA approval for ANDA212069, expanding its generic drug portfolio and positioning ...

SANDOZ
FDA Approves Unknown Drug — SANDOZ

# FDA Approves Sandoz Generic Drug Application Sandoz has received FDA approval for its abbreviated new drug application (ANDA 212068), expanding the...

FDA
FDA Authorizes Four Glas Electronic Nicotine Delivery System Products

The FDA approved the marketing of four Glas ENDS products through the premarket tobacco product application pathway. This authorization expands market...

ZHEJIANG
FDA Approves Unknown Drug — ZHEJIANG NOVUS

Zhejiang Novus announced the receipt of FDA approval for its ANDA, a strategic milestone expected to bolster the company’s commercial portfolio and dr...

Caplin
FDA Approves CALCIUM GLUCONATE — Caplin Steriles Limited

# FDA Approves Caplin Steriles Limited's Intravenous Calcium Gluconate Generic The FDA has approved Caplin Steriles Limited's abbreviated new drug ap...

YICHANG
FDA Approves Unknown Drug — YICHANG HUMANWELL

# FDA Approves Generic Drug Application from Yichang Humanwell Yichang Humanwell has received FDA approval for an abbreviated new drug application (A...

FDA
FDA Clears Expanded Access for Revolution Medicines' Pancreatic Cancer Drug

The FDA issued a 'safe to proceed' letter to Revolution Medicines for an expanded access treatment protocol of daraxonrasib, an experimental pancreati...

Federal
Federal Reserve Agencies Issue Host State Loan-to-Deposit Ratios

Federal banking agencies have released loan-to-deposit ratios for host states, providing updated metrics on lending activity relative to deposits acro...

Arvinas
FDA Approves VEPPANU — Arvinas Operations, Inc.

# FDA Approves Arvinas' VEPPANU (Vepdegestrant) for Oral Administration Arvinas Operations, Inc. received FDA approval for VEPPANU (vepdegestrant), a...

APOTEX
FDA Approves Unknown Drug — APOTEX

# FDA Approves New Drug Application for Apotex Apotex received FDA approval for NDA220837 on May 1, 2026, positioning the Canadian pharmaceutical man...

Incyte
FDA Approves JAKAFI XR — Incyte Corporation

# FDA Approves Incyte's JAKAFI XR Extended-Release Formulation Incyte Corporation received FDA approval for JAKAFI XR (ruxolitinib), an extended-rele...

MICRO
FDA Approves Unknown Drug — MICRO LABS

MICRO LABS secured FDA approval for ANDA217239, a regulatory clearance that is expected to diversify the company's product portfolio and generate incr...

IPCA
FDA Approves Unknown Drug — IPCA LABS LTD

FDA has approved the generic version of the referenced drug manufactured by IPCA LABS LTD, representing a new entry in the market. The anticipated app...

FDA
FDA Approves Auvelity as First Non-Antipsychotic for Dementia-Related Agitation

The FDA approved an expanded use for Auvelity (dextromethorphan/bupropion) to treat agitation associated with Alzheimer's dementia in adults. This mar...

FDA
FDA Proposes to Exclude Semaglutide, Tirzepatide, Liraglutide from 503B Bulks List

The FDA is proposing to remove semaglutide, tirzepatide, and liraglutide from the 503B bulks list, determining there is no clinical need for outsourci...

Apotex
FDA Approves SITAGLIPTIN AND METFORMIN HYDROCHLORIDE — Apotex Corp.

# FDA Approves Generic Sitagliptin and Metformin Hydrochloride Combination Apotex Corp. received FDA approval for its generic sitagliptin and metform...

BPI
FDA Approves FLUORESCEIN — BPI Labs LLC

# FDA Approves BPI Labs' Generic Fluorescein Sodium for Intravenous Use The FDA has approved BPI Labs LLC's abbreviated new drug application for gene...

UNICHEM
FDA Approves Unknown Drug — UNICHEM

UNICHEM announced FDA approval of ANDA 219593 effective April 30, 2026, a milestone expected to bolster its market presence and diversify its revenue ...